Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention

BACKGROUND: There is a paucity of real-world outcome data comparing clopidogrel, prasugrel and ticagrelor in primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI). We sought to assess the association of choice of oral P2Y12-receptor inhibitor with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnamurthy, Arvindra, Keeble, Claire, Anderson, Michelle, Somers, Kathryn, Burton-Wood, Natalie, Harland, Charlotte, Baxter, Paul, McLenachan, Jim, Blaxill, Jonathan, Blackman, Daniel J, Malkin, Christopher, Wheatcroft, Stephen, Greenwood, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Interventional Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609142/
https://www.ncbi.nlm.nih.gov/pubmed/31328001
http://dx.doi.org/10.1136/openhrt-2018-000951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609142/
https://www.ncbi.nlm.nih.gov/pubmed/31328001
http://dx.doi.org/10.1136/openhrt-2018-000951

Ejemplares similares